Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study
Abstract Late onset Pompe disease (LOPD) is a slow, progressive disorder characterized by skeletal and respiratory muscle weakness. Enzyme replacement therapy (ERT) slows down the progression of muscle symptoms. Reliable biomarkers are needed to follow up ERT-treated and asymptomatic LOPD patients i...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/92acffe4ea3d495381a7f63dd8c21825 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:92acffe4ea3d495381a7f63dd8c21825 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:92acffe4ea3d495381a7f63dd8c218252021-12-02T15:08:37ZQuantitative muscle MRI to follow up late onset Pompe patients: a prospective study10.1038/s41598-018-29170-72045-2322https://doaj.org/article/92acffe4ea3d495381a7f63dd8c218252018-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-29170-7https://doaj.org/toc/2045-2322Abstract Late onset Pompe disease (LOPD) is a slow, progressive disorder characterized by skeletal and respiratory muscle weakness. Enzyme replacement therapy (ERT) slows down the progression of muscle symptoms. Reliable biomarkers are needed to follow up ERT-treated and asymptomatic LOPD patients in clinical practice. In this study, 32 LOPD patients (22 symptomatic and 10 asymptomatic) underwent muscle MRI using 3-point Dixon and were evaluated at the time of the MRI with several motor function tests and patient-reported outcome measures, and again after one year. Muscle MRI showed a significant increase of 1.7% in the fat content of the thigh muscles in symptomatic LOPD patients. In contrast, there were no noteworthy differences between muscle function tests in the same period of time. We did not observe any significant changes either in muscle MRI or in muscle function tests in asymptomatic patients over the year. We conclude that 3-point Dixon muscle MRI is a useful tool for detecting changes in muscle structure in symptomatic LOPD patients and could become part of the current follow-up protocol in daily clinics.Sebastian Figueroa-BonaparteJaume LlaugerSonia SegoviaIzaskun BelmonteIrene PedrosaElena MontielPaula MontesinosJavier Sánchez-GonzálezAlicia Alonso-JiménezEduard GallardoIsabel IllaSpanish Pompe groupJordi Díaz-ManeraNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-11 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Sebastian Figueroa-Bonaparte Jaume Llauger Sonia Segovia Izaskun Belmonte Irene Pedrosa Elena Montiel Paula Montesinos Javier Sánchez-González Alicia Alonso-Jiménez Eduard Gallardo Isabel Illa Spanish Pompe group Jordi Díaz-Manera Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study |
description |
Abstract Late onset Pompe disease (LOPD) is a slow, progressive disorder characterized by skeletal and respiratory muscle weakness. Enzyme replacement therapy (ERT) slows down the progression of muscle symptoms. Reliable biomarkers are needed to follow up ERT-treated and asymptomatic LOPD patients in clinical practice. In this study, 32 LOPD patients (22 symptomatic and 10 asymptomatic) underwent muscle MRI using 3-point Dixon and were evaluated at the time of the MRI with several motor function tests and patient-reported outcome measures, and again after one year. Muscle MRI showed a significant increase of 1.7% in the fat content of the thigh muscles in symptomatic LOPD patients. In contrast, there were no noteworthy differences between muscle function tests in the same period of time. We did not observe any significant changes either in muscle MRI or in muscle function tests in asymptomatic patients over the year. We conclude that 3-point Dixon muscle MRI is a useful tool for detecting changes in muscle structure in symptomatic LOPD patients and could become part of the current follow-up protocol in daily clinics. |
format |
article |
author |
Sebastian Figueroa-Bonaparte Jaume Llauger Sonia Segovia Izaskun Belmonte Irene Pedrosa Elena Montiel Paula Montesinos Javier Sánchez-González Alicia Alonso-Jiménez Eduard Gallardo Isabel Illa Spanish Pompe group Jordi Díaz-Manera |
author_facet |
Sebastian Figueroa-Bonaparte Jaume Llauger Sonia Segovia Izaskun Belmonte Irene Pedrosa Elena Montiel Paula Montesinos Javier Sánchez-González Alicia Alonso-Jiménez Eduard Gallardo Isabel Illa Spanish Pompe group Jordi Díaz-Manera |
author_sort |
Sebastian Figueroa-Bonaparte |
title |
Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study |
title_short |
Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study |
title_full |
Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study |
title_fullStr |
Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study |
title_full_unstemmed |
Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study |
title_sort |
quantitative muscle mri to follow up late onset pompe patients: a prospective study |
publisher |
Nature Portfolio |
publishDate |
2018 |
url |
https://doaj.org/article/92acffe4ea3d495381a7f63dd8c21825 |
work_keys_str_mv |
AT sebastianfigueroabonaparte quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy AT jaumellauger quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy AT soniasegovia quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy AT izaskunbelmonte quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy AT irenepedrosa quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy AT elenamontiel quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy AT paulamontesinos quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy AT javiersanchezgonzalez quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy AT aliciaalonsojimenez quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy AT eduardgallardo quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy AT isabelilla quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy AT spanishpompegroup quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy AT jordidiazmanera quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy |
_version_ |
1718388074331766784 |